Track the 종근당 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 종근당 has recorded 6 public disclosures. Market capitalisation: €865.7bn. The latest transaction was disclosed on 26 June 2026 (Sale). Among the most active insiders: 이장한. Every trade is openly available.
Analysts rate 종근당 Buy (bullish), based on 7 analysts. Average price target: ₩113,571.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
6 of 6 declarations
종근당 is a South Korean company specializing in the health and pharmaceutical sector. It is listed on the XKRX stock exchange.